Athena Robinson

Athena Robinson, PhD is Chief Clinical Officer at Woebot Health and Adjunct Clinical Associate Professor at Stanford’s School of Medicine. At Woebot Health, Athena oversees the company’s regulatory strategy and overall program of research, as well as the empirically-supported psychotherapeutic underpinnings of the Woebot Health products.

Athena’s areas of expertise include evidence-based digital therapeutics, implementation science, and treatment-outcome behavioral health research. She is the recipient of a number of research awards and fellowships, including from the National Institutes of Drug Abuse, the National Institutes of Mental Health, the National Cancer Institute, the NCAA, and Stanford University. Athena is also the author of dozens of original peer-reviewed research publications, articles, books and book chapters on subjects ranging from digital mental health technology to eating disorders and professional well being, and is an ad hoc reviewer for several professional psychiatric and clinical psychology journals. Athena holds a PhD with a specialty in behavioral medicine from the Joint Doctoral Program at the University of California, San Diego/San Diego State University, an MS in clinical psychology from San Diego State University and a BA in psychology and social welfare from the University of California, Berkeley. An expert in evidence-based interventions for a variety of psychiatric indications among both adults and adolescents, Athena is also a licensed clinical psychologist and continues her private practice in the state of California.